Hood River Capital Management LLC Madrigal Pharmaceuticals, Inc. Transaction History
Hood River Capital Management LLC
- $5.79 Billion
- Q4 2024
A detailed history of Hood River Capital Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 127,839 shares of MDGL stock, worth $41.9 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
127,839Holding current value
$41.9 Million% of portfolio
0.68%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
336Shares Held
22.2MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$724 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$670 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$665 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$654 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$647 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.61B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...